A 2023 retrospective cohort study found semaglutide significantly reduced binge eating episodes in patients with BED the first study of its kind A 2020 pilot study of dulaglutide found it reduced binge episodes in patients with type 2 diabetes and BED A 2026 meta-analysis found liraglutide reduced binge frequency by approximately 1.28 fewer episodes per week compared to placebo A rapid review of 25 studies encompassing over 8,700 adult patients found that binge eating episodes and prevalence reduced following liraglutide and semaglutide An observational study of 69 people with obesity found emotional eating dropped from 72.5% to 11.5% after three months of semaglutide The Critical Caveats Despite a promising early signal, these findings should be held carefully
According to the International Diabetes Federation, there are currently 425 million diabetic patients worldwide, and it is estimated that by 2045, there will be nearly 700 million diabetic patients
Vandetanib treatment produces significant side effects, including diarrhea, rash, hypertension, and QT prolongation
BioTE Nutraceuticals have been carefully formulated to support bioidentical hormone replacement therapy (BHRT), promote healthy aging, and enhance overall wellness
